Hepatitis E Clinical Trial
Official title:
Observational Study on Seroprevalence of Hepatitis E Infection in Healthy Blood Donors in the Canton Ticino
This is a HEV seroprevalence in the health donors in the Canton Ticino study. The pre-donation sampling pouch of each blood donor coming form the Cantone Ticino region will be collected and tested for HEV serology (IgM and IgG).
Pre-donation sampling pouch of fresh and stored frozen plasma collected within the last 5 years will be tested for HEV IgG serology at the National Reference Laboratory of the Blood Transfusion Services SRC in Berne Collected data will be used to determine HEV seroprevalence, actual and in the last 5 years, in the Canton Ticino and to investigate trend and pattern of the HEV infection (seroprevalence by different regional areas, comparison with national HEV data, and correlation with age, sex and place of residence). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03365921 -
A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Lot Consistency Trial)
|
Phase 4 | |
Completed |
NCT02584543 -
A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine)
|
Phase 4 | |
Not yet recruiting |
NCT03488589 -
HEV in Patients With Acute Non-A, Non-B, Non-C Hepatitis in Al-Rajhy University Hospital for Liver
|
||
Completed |
NCT03168412 -
A Study on the Recombinant Hepatitis E Vaccine (Escherichia Coli) (Accelerated Vaccination Schedule)
|
Phase 4 | |
Completed |
NCT02189603 -
Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine(Hecolin®)
|
Phase 4 | |
Completed |
NCT02847507 -
Seroprevalence of Hepatitis E in HIV Positive Patients in Basque Country in 2016 (VIhVhEpb)
|
||
Completed |
NCT02603055 -
A Clinical Trial to Evaluate a Recombinant Hepatitis E Vaccine in Healthy Adults
|
Phase 1 | |
Completed |
NCT02190253 -
Seroprevalence of Hepatitis E in People With an Organ Transplant
|
||
Recruiting |
NCT06457438 -
Molecular Characteristics and Prevalence of Viral Hepatitis E in Human Tissue and Cell Donors
|
N/A | |
Completed |
NCT04670419 -
Morbidity and Mortality of Hepatitis E Virus Infections in Belgium
|
||
Completed |
NCT03282474 -
HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE)
|
Phase 2 | |
Terminated |
NCT02558114 -
Ribavirin for Severe Acute and Chronic Hepatitis E Virus Infection.
|
Phase 4 | |
Recruiting |
NCT06137313 -
Exposure to Hepatitis E Virus in Occitania, France
|
||
Completed |
NCT02964910 -
A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Chronic Hepatitis B Patients )
|
Phase 4 | |
Completed |
NCT01014845 -
Clinical Trial of Recombinant Hepatitis E Vaccine
|
Phase 3 | |
Recruiting |
NCT05976594 -
Long-term Effectiveness of a Recombinant Hepatitis E Vaccine
|
||
Completed |
NCT02417597 -
A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)
|
Phase 4 | |
Completed |
NCT03827395 -
Safety Study of Hepatitis E Vaccine (HEV239)
|
Phase 1 |